Amarin Corporation plc (AMRN)

CIK 0000897448 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-29) · 99.1
Q1-2026 8-K (2026-04-29) · 99.1
Latest FY-2025 8-K (2026-02-25) · 99.1  |  8-K (2026-01-08) · 99.1
Q3-2025 8-K (2025-10-29) · 99.1
Q2-2025 8-K (2025-07-30) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-03-12) · 99.1 · 99.2
Q3-2024 8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-07-31) · 99.1
Q1-2024 8-K (2024-05-01) · 99.1
FY-2023 8-K (2024-02-29) · 99.1  |  8-K (2024-01-10) · 99.1 · 99.2
Q3-2023 8-K (2023-11-01) · 99.1
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statement of Changes In Stockholders' Equity
—
Consolidated Statements of Stockholders' Equity
—
Consolidated Statements of Cash Flows
Notes
Accrued Expenses and Other Current Liabilities
—
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Defined Contribution Plan
—
Development, Commercialization and Supply Agreements
Equity
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Asset
Inventory
Leases
Nature of Business and Basis of Presentation
Pay Vs Performance Disclosure
Property, Plant and Equipment
—
Revenue Recognition
Significant Accounting Policies
Stock Incentive Plans and Stock-based Compensation
—